NCT00126555 2019-08-30Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin CancerNational Cancer Institute (NCI)Phase 2 Completed23 enrolled 12 charts